REATMENT WITH THE ANTICHOLESTEROL MEDICINE ROSUVASTATIN CALCIUM DID NOT REDUCE THE RISK OF FRACTURE AMONG MEN AND WOMEN WHO HAD ELEVATED LEVELS OF AN INFLAMMATORY BIOMARKER, ACCORDING TO A REPORT PUBLISHED ONLINE BY JAMA INTERNAL MEDIC
REATMENT WITH THE ANTICHOLESTEROL MEDICINE ROSUVASTATIN CALCIUM DID NOT REDUCE THE RISK OF FRACTURE AMONG MEN AND WOMEN WHO HAD ELEVATED LEVELS OF AN INFLAMMATORY BIOMARKER, ACCORDING TO A REPORT PUBLISHED ONLINE BY JAMA INTERNAL MEDIC
Be the first to reply